SAN FRANCISCO--(BUSINESS WIRE)--
Invitae
Corporation (NYSE:
NVTA), a genetic information company, today announced that it will
host an investor conference call on Wednesday, October 7 at 4:30 p.m.
Eastern / 1:30 p.m. Pacific. Invitae’s management team will discuss the
company’s expanded genetic testing menu.
The dial-in numbers for the conference call are (877) 201-0168 for
domestic callers and (647) 788-4901 for international callers, and the
reservation number for both is 55474881.
The live, listen-only webcast of the conference call may be accessed by
visiting the investors section of the company’s website at ir.invitae.com.
A replay of the webcast will be available shortly after the conclusion
of the call and will be archived on the company’s website.
About Invitae
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive
genetic information into mainstream medical practice to improve the
quality of healthcare for billions of people. Invitae’s goal is to
aggregate most of the world’s genetic tests into a single service with
higher quality, faster turnaround time, and lower price than many
single-gene and panel tests today. The company currently provides a
single diagnostic service comprising hundreds of genes for a variety of
genetic disorders associated with oncology, cardiology, neurology,
pediatrics and other rare disease areas.
For more information, visit our website at ir.invitae.com
and follow us on @twitter: @invitae
and @invitaeIR.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151006006728/en/
Source: Invitae Corporation